Cargando…
A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma
BACKGROUND: Osteoporosis could be associated with the hormone therapy for metastatic prostate carcinoma (PCa) and with PCa per se. The objective of this review is to determine the incidence of bone loss and osteoporosis in patients with PCa who are or are not treated with hormone therapy (ADT). METH...
Autores principales: | Serpa Neto, Ary, Tobias-Machado, Marcos, Esteves, Marcos AP, Senra, Marília D, Wroclawski, Marcelo L, Fonseca, Fernando LA, dos Reis, Rodolfo B, Pompeo, Antônio CL, Del Giglio, Auro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882358/ https://www.ncbi.nlm.nih.gov/pubmed/20482867 http://dx.doi.org/10.1186/1471-2490-10-9 |
Ejemplares similares
-
The influence of testosterone suppression on HER2 immunoexpression in prostatic neoplastic tissue
por: Peixoto, Guilherme Andrade, et al.
Publicado: (2021) -
Open suprapubic versus retropubic prostatectomy in the treatment of benign prostatic hyperplasia during resident's learning curve: a randomized controlled trial
por: Carneiro, Arie, et al.
Publicado: (2016) -
Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report
por: del Giglio, Auro, et al.
Publicado: (2023) -
New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough
por: Wroclawski, Marcelo Langer
Publicado: (2017) -
Are localized prostate cancer biomarkers useful in the clinical practice?
por: Carneiro, Arie, et al.
Publicado: (2018)